Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a government-funding notice and updated the version to v3.2.0; removed the prior v3.1.0 tag.SummaryDifference10%
- Check21 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedUpdated the page from Revision: v3.0.1 to Revision: v3.0.2, indicating a minor update; the 'Back to Top' link was removed.SummaryDifference0.6%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.6%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple study status updates spanning from 2018 to 2025. However, several location-related terms have been removed.SummaryDifference46%
- Check64 days agoChange DetectedThe page has updated its version from v2.16.11 to v2.16.12 and changed the date from 2025-05-14 to 2025-08-14.SummaryDifference0.7%
Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.